PRNewsWire · BBNX · October 21, 2026Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance - Hagens BermanGet the app for moreExplore stock news, insights and company research.Get the app →Source: PRNewsWire ↗